Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2024 Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2024 Earnings Call Transcript August 8, 2024

Intellia Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.5156 EPS, expectations were $-1.21.

Operator: Good morning, and welcome to Intellia Therapeutics’ Second Quarter 2024 Financial Results Conference Call. My name is Drew and I will be your conference operator today. Following formal remarks, we will open the call up for a question-and-answer session. This conference is...